The Goldman Sachs Group Issues Positive Forecast for Calumet (NASDAQ:CLMT) Stock Price

Calumet (NASDAQ:CLMTGet Free Report) had its price objective upped by The Goldman Sachs Group from $40.00 to $45.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “neutral” rating on the oil and gas company’s stock. The Goldman Sachs Group’s price objective points to a potential downside of 6.93% from the company’s current price.

A number of other brokerages have also issued reports on CLMT. Citigroup reaffirmed a “buy” rating on shares of Calumet in a research report on Monday, August 10th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Calumet in a research report on Friday, August 7th. Finally, TD Cowen lifted their target price on Calumet from $34.00 to $40.00 and gave the stock a “hold” rating in a research report on Wednesday, August 12th. Two analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Calumet presently has a consensus rating of “Hold” and a consensus price target of $42.75.

Get Our Latest Analysis on CLMT

Calumet Stock Performance

CLMT opened at $48.35 on Tuesday. Calumet has a twelve month low of $12.94 and a twelve month high of $49.17. The firm has a market cap of $4.25 billion, a P/E ratio of -31.19 and a beta of 0.71. The business has a 50 day moving average price of $39.30 and a 200 day moving average price of $33.82.

Calumet (NASDAQ:CLMTGet Free Report) last released its quarterly earnings results on Friday, August 7th. The oil and gas company reported ($1.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($1.16). The business had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.12 billion. Calumet’s revenue for the quarter was up 40.8% on a year-over-year basis. During the same period last year, the business earned ($1.70) EPS. As a group, analysts anticipate that Calumet will post 0.46 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Calumet news, Director Daniel J. Sajkowski sold 4,240 shares of the business’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $36.16, for a total value of $153,318.40. Following the sale, the director owned 77,718 shares of the company’s stock, valued at $2,810,282.88. The trade was a 5.17% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 3.15% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CLMT. Islay Capital Management LLC acquired a new position in shares of Calumet in the 4th quarter worth approximately $25,000. Aster Capital Management DIFC Ltd boosted its stake in Calumet by 294.7% in the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock valued at $33,000 after buying an additional 1,229 shares in the last quarter. Global Retirement Partners LLC acquired a new stake in Calumet in the 2nd quarter valued at $61,000. KBC Group NV bought a new stake in Calumet in the first quarter valued at $69,000. Finally, Covestor Ltd grew its position in Calumet by 29.1% in the fourth quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock valued at $43,000 after acquiring an additional 492 shares during the period. Institutional investors own 34.41% of the company’s stock.

About Calumet

(Get Free Report)

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.

Recommended Stories

Analyst Recommendations for Calumet (NASDAQ:CLMT)

Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.